Shen Lian Biomedical released its performance for the first three quarters, with a net profit attributable to the parent company of 280,000 yuan, turning a profit compared to the same period last year

According to the Zhitong Finance APP, Shen Lian Biomedical (688098.SH) disclosed its third-quarter report for 2025. The company achieved revenue of 238 million yuan in the first three quarters, a year-on-year decrease of 4.27%; the net profit attributable to shareholders was 280,000 yuan, turning from a loss to a profit year-on-year; the net profit excluding non-recurring gains and losses was a loss of 5.1 million yuan; basic earnings per share were 0 yuan